Evaluation of the Safety and Efficacy of Infantile-onset Pompe Disease Gene Therapy Drug
Clinical trial NCT05793307 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT05793307
- Sponsor
- GeneCradle Inc
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2023-06-02
- Primary completion
- 2025-12-01
- Enrollment
- 16
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.